Drugs / BCG
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02063555 Comparator | Feb 2014 → Mar 2016 | tuberculosis | Dartmouth-Hitchcock Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02063555 ↗ |
| Modality | Vaccine | “BCG, a vaccine that has been shown ineffective as a booster to prevent tuberculosis disease.” PMID 31120957 ↗ May 2019 |